Jonette Green1, Arif Yurdagul2, Marshall C McInnis1, Patrick Albert1, A Wayne Orr3. 1. Department of Pathology, LSU Health Sciences Center - Shreveport, Biomedical Research Institute, Rm. 6-21, 1501 Kings Hwy, Shreveport, LA 71130, USA. 2. Department of Cell Biology and Anatomy, LSU Health Sciences Center - Shreveport, Shreveportt, LA 71130, USA. 3. Department of Pathology, LSU Health Sciences Center - Shreveport, Biomedical Research Institute, Rm. 6-21, 1501 Kings Hwy, Shreveport, LA 71130, USA; Department of Cell Biology and Anatomy, LSU Health Sciences Center - Shreveport, Shreveportt, LA 71130, USA. Electronic address: aorr@lsuhsc.edu.
Abstract
OBJECTIVE: Altered subendothelial matrix composition regulates endothelial dysfunction and early atherosclerotic plaque formation. Hyperglycemia promotes endothelial matrix remodeling associated with multiple microvascular complications of diabetes, but a role for altered matrix composition in diabetic atherogenesis has not been described. Therefore, we sought to characterize the alterations in matrix composition during diabetic atherogenesis using both in vitro and in vivo model systems. METHODS AND RESULTS: Streptozotocin-induced diabetes in atherosclerosis-prone ApoE knockout mice promoted transitional matrix expression (fibronectin, thrombospondin-1) and deposition in intima of the aortic arch as determined by qRT-PCR array and immunohistochemistry. Early plaque formation occurs at discrete vascular sites exposed to disturbed blood flow patterns, whereas regions exposed to laminar flow are protected. Consistent with this pattern, hyperglycemia-induced transitional matrix deposition was restricted to regions of disturbed blood flow. Laminar flow significantly blunted high glucose-induced fibronectin expression (mRNA and protein) and fibronectin fibrillogenesis in endothelial cell culture models, whereas high glucose-induced fibronectin deposition was similar between disturbed flow and static conditions. CONCLUSIONS: Taken together, these data demonstrate that flow patterns and hyperglycemia coordinately regulate subendothelial fibronectin deposition during early atherogenesis.
OBJECTIVE: Altered subendothelial matrix composition regulates endothelial dysfunction and early atherosclerotic plaque formation. Hyperglycemia promotes endothelial matrix remodeling associated with multiple microvascular complications of diabetes, but a role for altered matrix composition in diabetic atherogenesis has not been described. Therefore, we sought to characterize the alterations in matrix composition during diabetic atherogenesis using both in vitro and in vivo model systems. METHODS AND RESULTS:Streptozotocin-induced diabetes in atherosclerosis-prone ApoE knockout mice promoted transitional matrix expression (fibronectin, thrombospondin-1) and deposition in intima of the aortic arch as determined by qRT-PCR array and immunohistochemistry. Early plaque formation occurs at discrete vascular sites exposed to disturbed blood flow patterns, whereas regions exposed to laminar flow are protected. Consistent with this pattern, hyperglycemia-induced transitional matrix deposition was restricted to regions of disturbed blood flow. Laminar flow significantly blunted high glucose-induced fibronectin expression (mRNA and protein) and fibronectin fibrillogenesis in endothelial cell culture models, whereas high glucose-induced fibronectin deposition was similar between disturbed flow and static conditions. CONCLUSIONS: Taken together, these data demonstrate that flow patterns and hyperglycemia coordinately regulate subendothelial fibronectin deposition during early atherogenesis.
Authors: David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman Journal: N Engl J Med Date: 2005-12-22 Impact factor: 91.245
Authors: Michelle H Tan; Zhengwu Sun; Sarah L Opitz; Tracy E Schmidt; John H Peters; Elizabeth L George Journal: Blood Date: 2004-02-19 Impact factor: 22.113
Authors: M A Ihnat; J E Thorpe; C D Kamat; C Szabó; D E Green; L A Warnke; Z Lacza; A Cselenyák; K Ross; S Shakir; L Piconi; R C Kaltreider; A Ceriello Journal: Diabetologia Date: 2007-05-17 Impact factor: 10.122
Authors: Jason L Johnson; Laurent Devel; Bertrand Czarny; Sarah J George; Christopher L Jackson; Vassilis Rogakos; Fabrice Beau; Athanasios Yiotakis; Andrew C Newby; Vincent Dive Journal: Arterioscler Thromb Vasc Biol Date: 2011-01-06 Impact factor: 8.311
Authors: A Wayne Orr; John M Sanders; Melissa Bevard; Elizabeth Coleman; Ian J Sarembock; Martin Alexander Schwartz Journal: J Cell Biol Date: 2005-04-04 Impact factor: 10.539
Authors: Chan Woo Kim; Anastassia Pokutta-Paskaleva; Sandeep Kumar; Lucas H Timmins; Andrew D Morris; Dong-Won Kang; Sidd Dalal; Tatiana Chadid; Katie M Kuo; Julia Raykin; Haiyan Li; Hiromi Yanagisawa; Rudolph L Gleason; Hanjoong Jo; Luke P Brewster Journal: Circulation Date: 2017-08-04 Impact factor: 29.690
Authors: Nicolas Baeyens; Chirosree Bandyopadhyay; Brian G Coon; Sanguk Yun; Martin A Schwartz Journal: J Clin Invest Date: 2016-03-01 Impact factor: 14.808
Authors: Alexandra C Finney; Steven D Funk; Jonette M Green; Arif Yurdagul; Mohammad Atif Rana; Rebecca Pistorius; Miriam Henry; Andrew Yurochko; Christopher B Pattillo; James G Traylor; Jin Chen; Matthew D Woolard; Christopher G Kevil; A Wayne Orr Journal: Circulation Date: 2017-05-09 Impact factor: 29.690
Authors: Zaki Al-Yafeai; Arif Yurdagul; Jonette M Peretik; Mabruka Alfaidi; Patrick A Murphy; A Wayne Orr Journal: Arterioscler Thromb Vasc Biol Date: 2018-11 Impact factor: 8.311
Authors: Zaki Al-Yafeai; Brenna H Pearson; Jonette M Peretik; Elizabeth D Cockerham; Kaylea A Reeves; Umesh Bhattarai; Dongdong Wang; Brian G Petrich; A Wayne Orr Journal: Matrix Biol Date: 2020-11-04 Impact factor: 11.583